Allen Investment Management LLC United Therapeutics Corp Transaction History

Allen Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$78.31 - $95.34 $463,830 - $564,698	-5,923 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$107.15 - $126.84 $634,649 - $751,273	5,923 New	5,923 $695,000
Q4 2018 Feb 05, 2019	SELL	$101.4 - $128.73 $652,407 - $828,248	-6,434 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$114.6 - $136.81 $294,063 - $351,054	2,566 Added 66.34%	6,434 $754,000
Q3 2015 Sep 22, 2017	BUY	N/A	971 Added 33.52%	3,868 $508,000
Q4 2014 Sep 22, 2017	BUY	N/A	2,897	2,897 $375,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Allen Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Allen Investment Management LLC with notifications on news.